(Q37661506)

21 August 2017

1 reference

title

Ferumoxytol: a new intravenous iron preparation for the treatment of iron deficiency anemia in patients with chronic kidney disease (English)

1 reference

21 August 2017

0 references

1 reference

iron deficiency anemia

1 reference

Michael H Schwenk

1

1 reference

21 August 2017

language of work or name

English

0 references

publication date

1 January 2010

1 reference

21 August 2017

1 reference

21 August 2017

volume

30

1 reference

21 August 2017

issue

1

1 reference

21 August 2017

page(s)

70-79

1 reference

Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.1.70

Iron management in end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.1.70

Iron indices in chronic kidney disease in the National Health and Nutritional Examination Survey 1988-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.1.70

Physicochemical properties of ferumoxytol, a new intravenous iron preparation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.1.70

Pharmacokinetic study of ferumoxytol: a new iron replacement therapy in normal subjects and hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.1.70

Ferumoxytol for treating iron deficiency anemia in CKD

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.1.70

Ferumoxytol as an intravenous iron replacement therapy in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.1.70

Ultrasmall superparamagnetic iron oxides (USPIOs): a future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic systemic fibrosis (NSF)?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.1.70

New insights into nephrogenic systemic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.1.70

Intravenous versus oral iron supplementation for the treatment of anemia in CKD: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.1.70

Update on adverse drug events associated with parenteral iron

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.1.70

Sodium ferric gluconate complex in sucrose is safe and effective in hemodialysis patients: North American Clinical Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.1.70

Low-molecular weight iron dextran and iron sucrose have similar comparative safety profiles in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.1.70

The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.1.70

21 January 2018

Identifiers

DOI

10.1592/PHCO.30.1.70

1 reference

21 August 2017

1 reference